138 related articles for article (PubMed ID: 10365755)
1. Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain.
Shibata M; Shima M; Fujimura Y; Takahashi Y; Nakai H; Sakurai Y; Asatani M; Nomura A; Take H; Giddings JC; Yoshioka A
Thromb Haemost; 1999 May; 81(5):793-8. PubMed ID: 10365755
[TBL] [Abstract][Full Text] [Related]
2. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody selectively inhibits binding of von Willebrand factor to glycoprotein ib. Recognition site is located in the A1 loop of von Willebrand factor.
Mohri H; Yamazaki E; Suzuki Z; Takano T; Yokota S; Okubo T
Thromb Haemost; 1997 Apr; 77(4):760-6. PubMed ID: 9134656
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
South V; Searfoss GH; French S; Cheadle C; Murray E; Howk R; Jaye M; Ricca GA
Thromb Haemost; 1995 Jan; 73(1):144-50. PubMed ID: 7537918
[TBL] [Abstract][Full Text] [Related]
7. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
8. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
10. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis.
Kroner PA; Frey AB
Biochemistry; 1996 Oct; 35(41):13460-8. PubMed ID: 8873615
[TBL] [Abstract][Full Text] [Related]
12. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx.
Mazzucato M; De Marco L; Pradella P; Masotti A; Pareti FI
Thromb Haemost; 1996 Apr; 75(4):655-60. PubMed ID: 8743195
[TBL] [Abstract][Full Text] [Related]
13. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationship of the A1 domain of von Willebrand factor.
Girma JP; Ribba AS; Meyer D
Thromb Haemost; 1995 Jul; 74(1):156-60. PubMed ID: 8578449
[TBL] [Abstract][Full Text] [Related]
15. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
[TBL] [Abstract][Full Text] [Related]
16. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
Verkleij MW; IJsseldijk MJ; Heijnen-Snyder GJ; Huizinga EG; Morton LF; Knight CG; Sixma JJ; de Groot PG; Barnes MJ
Thromb Haemost; 1999 Sep; 82(3):1137-44. PubMed ID: 10494778
[TBL] [Abstract][Full Text] [Related]
17. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
Kang M; Wilson L; Kermode JC
Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
[TBL] [Abstract][Full Text] [Related]
18. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D
Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314
[TBL] [Abstract][Full Text] [Related]
19. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y
Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497
[TBL] [Abstract][Full Text] [Related]
20. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction.
Schulte am Esch J; Robson SC; Knoefel WT; Eisenberger CF; Peiper M; Rogiers X
Br J Haematol; 2005 Jan; 128(1):82-90. PubMed ID: 15606553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
